Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03634488 · ClinicalTrials.gov registry record · Phase 2
Management of Severe Acute Malnutrition in SCD, in Northern Nigeria
A Phase 2 study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 132
- Enrollment target
NCT03634488 is a Phase 2 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 132 participants.
The verdict
NCT03634488, a Phase 2 study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 132 participants
- Enrollment target
Study Summary
Except for children with HIV, all recommendations for treatment of childhood malnutrition are for children \< 5 years of age. The overall goal of this randomized controlled nutrition feasibility trial is to identify whether families of children with sickle cell disease (SCD) 5 years and older agree to participate over a 12-week period. The investigators will also establish a safety protocol for monitoring potential complications associated with treating severe malnutrition in children 5 years and older with and without SCD, in a low-resource setting.
Interventions
- DRUG hydroxyurea (20mg/kg/day)
- DIETARY_SUPPLEMENT Ready-to-use therapeutic food
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2021-08-18 |
| Est. Completion | 2022-11-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03634488
The ClinicalTrials.gov registry entry for NCT03634488 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which hydroxyurea (20mg/kg/day) is the first listed.
NCT03634488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03634488 about?
NCT03634488 is a clinical study titled "Management of Severe Acute Malnutrition in SCD, in Northern Nigeria". Except for children with HIV, all recommendations for treatment of childhood malnutrition are for children \< 5 years of age. The overall goal of this randomized controlled nutrition feasibility trial is to identify whether families of children with sickle cell disease (SCD) 5 years and older agree ...
What is the current status of trial NCT03634488?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 132 participants. The study started on 2021-08-18. Estimated completion is 2022-11-09.
What interventions are being tested in trial NCT03634488?
The interventions under investigation include: hydroxyurea (20mg/kg/day) (DRUG), Ready-to-use therapeutic food (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03634488?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.